DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,034 filers reported holding DANAHER CORPORATION in Q1 2023. The put-call ratio across all filers is 0.99 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $44,147,411 | +2.2% | 177,942 | -1.1% | 2.17% | +9.1% |
Q2 2023 | $43,199,135 | -0.7% | 179,996 | +4.3% | 1.99% | -5.8% |
Q1 2023 | $43,513,775 | -6.2% | 172,646 | -1.3% | 2.11% | -11.0% |
Q4 2022 | $46,408,527 | -1.5% | 174,849 | -4.2% | 2.38% | -8.3% |
Q3 2022 | $47,127,000 | +0.9% | 182,458 | -1.0% | 2.59% | +6.5% |
Q2 2022 | $46,710,000 | -15.3% | 184,246 | -2.0% | 2.43% | +3.5% |
Q1 2022 | $55,130,000 | -12.8% | 187,944 | -2.2% | 2.35% | -4.2% |
Q4 2021 | $63,199,000 | +6.9% | 192,088 | -1.1% | 2.46% | +0.3% |
Q3 2021 | $59,133,000 | +8.3% | 194,236 | -4.6% | 2.45% | +10.7% |
Q2 2021 | $54,622,000 | +16.3% | 203,540 | -2.4% | 2.21% | +7.9% |
Q1 2021 | $46,958,000 | -0.5% | 208,630 | -1.8% | 2.05% | -6.0% |
Q4 2020 | $47,193,000 | +2.1% | 212,446 | -1.0% | 2.18% | -9.0% |
Q3 2020 | $46,211,000 | +21.5% | 214,606 | -0.2% | 2.40% | +10.7% |
Q2 2020 | $38,024,000 | +26.3% | 215,034 | -1.1% | 2.17% | +2.0% |
Q1 2020 | $30,102,000 | -18.5% | 217,484 | -9.6% | 2.12% | +7.8% |
Q4 2019 | $36,916,000 | +2294.0% | 240,527 | +2153.0% | 1.97% | +1178.6% |
Q3 2019 | $1,542,000 | +206.0% | 10,676 | +202.9% | 0.15% | +190.6% |
Q2 2019 | $504,000 | – | 3,525 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |